Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Sonendo, Inc. (SONX : OTC)

• Company Description    Sonendo Inc. is a commercial-stage medical technology company focused on saving teeth from tooth decay. It developed the GentleWave(R) System an innovative technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. Sonendo Inc. is based in LAGUNA HILLS, Calif. Number of Employees: 131

• Price / Volume Information    Yesterday's Closing Price: $1.15 Daily Weekly Monthly 20 Day Moving Average: 87 shares Shares Outstanding: 0.43 (millions) Market Capitalization: $0.49 (millions) Beta: 1.46 52 Week High: $17.00 52 Week Low: $1.00 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -8.00% -12.09% 12 Week -7.26% -20.79% Year To Date -36.46% -40.49%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 26061 MERIT CIRCLE SUITE 102 - Laguna Hills,CA 92653 USA ph: 949-766-3636 fax: - ir@sonendo.com http://www.sonendo.com

• General Corporate Information    Officers Bjarne Bergheim - President; Chief Executive Officer and Director Anthony P. Bihl III - Chairman of the Board John Bostjancic - Chief Financial Officer John McGaugh - Senior Vice President of Operations Carolyn Beaver - Director Peer Information Sonendo, Inc. (HLIS) Sonendo, Inc. (AZTA) Sonendo, Inc. (APYI) Sonendo, Inc. (RNVA) Sonendo, Inc. (HMSY) Sonendo, Inc. (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 835431206 SIC: 3843 Fiscal Year Fiscal Year End: December Last Reported Quarter: 12/01/24 Next Expected EPS Date: 08/06/25 Share - Related Items Shares Outstanding: 0.43 Most Recent Split Date: 11.00 (0.01:1) Beta: 1.46 Market Capitalization: $0.49 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/06/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.09 Price/Cash Flow: - Price / Sales: 0.02 EPS Growth vs. Year Ago Period: 44.38% vs. Previous Quarter: 15.35% Sales Growth vs. Year Ago Period: -28.97% vs. Previous Quarter: 3.35% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - -228.13 ROA 06/30/25 - - 03/31/25 - - 12/31/24 - -77.45 Current Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - 1.39 Quick Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - 0.88 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - -105.34 Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - -88.43 Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - -105.80 Book Value 06/30/25 - - 03/31/25 - - 12/31/24 - 12.15 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - 1.74 Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - 0.70 Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - 41.20

Powered by Zacks Investment Research ©